BIOKANGTAI
Shenzhen Kangtai Biological Products Co., Ltd. is a listed company integrating research, development, production and sales of biological products.the company has R&D centers and industrial bases in Shenzhen and Beijing. It is one of the major hepatitis B vaccine manufacturers in China.The company's main business is the development, production and sales of human vaccines. The product categories cover Class I and Class II vaccines. The main products are recombinant hepatitis B vaccine (Saccharomyces cerevisiae), Haemophilus influenzae type b conjugate vaccine, and measles and rubella. Live attenuated vaccine, cell-free white-breaking Haemophilus influenzae type b combined vaccine, 23- valent pneumococcal polysaccharide vaccine and other products.
BIOKANGTAI
Industry:
Biotechnology
Address:
Guangdong, Jilin, China
Country:
China
Website Url:
http://www.biokangtai.com
Total Employee:
11+
Status:
Active
Contact:
86-755-26988688
Email Addresses:
http://[email protected]/
Total Funding:
0
Technology used in webpage:
IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Domain Not Resolving Apache IPv6 COVID-19 Cloudflare SSL Unified Layer
Stock Details
Investors List
6 Dimensions Capital
6 Dimensions Capital investment in Post-IPO Equity - Biokangtai
Tianmeng Xu
Tianmeng Xu investment in Venture Round - Biokangtai
Official Site Inspections
http://www.biokangtai.com Semrush global rank: 7.24 M Semrush visits lastest month: 548
- Host name: 119.136.30.138
- IP address: 119.136.30.138
- Location: Shenzhen China
- Latitude: 22.5333
- Longitude: 114.1333
- Timezone: Asia/Shanghai
More informations about "Biokangtai"
Biokangtai - Biokangtai
Since its establishment in 1992, BioKangtai has undertaken a number of national, provincial and municipal key scientific research projects and technology development tasks, and has …See details»
Biokangtai - Crunchbase Company Profile & Funding
Organization. Biokangtai . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Biokangtai is a listed company integrating …See details»
公司介绍 - 深圳康泰生物制品股份有限公司 - biokangtai.com
公司介绍深圳康泰生物制品股份有限公司成立于1992年，专注于人用疫苗的研发、生产、销售，2017年2月在深交所创业板上市（股票代码 ：300601），为华南地区首个上市疫苗企业。 …See details»
About Us - Biokangtai
BioKangtai and AstraZeneca's adenovirus vector COVID-19 vaccine is the first international anti epidemic cooperation project in Guangdong Province. The two sides jointly promote the …See details»
Shenzhen Kangtai Biological Products - Wikipedia
Shenzhen Kangtai Biological Products (Chinese: 深圳康泰生物制品股份有限公司, SZSE: 300601), also known as BioKangtai (Chinese: 康泰生物), is a ...See details»
BIOKANGTAI Company Profile 2024: Stock Performance
BIOKANGTAI General Information Description. Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research …See details»
Org Chart Biokangtai - The Official Board
Biokangtai has 3 executives. Biokangtai; Please confirm your deletion . Delete or Cancel . Unfortunately, you don't own enough credit to see this new org chart. To continue, you can …See details»
BioKangtai - Products, Competitors, Financials, Employees, …
BioKangtai is a company that focuses on the research, production, and sale of human vaccines, operating within the biotechnology and pharmaceutical industry. The company offers a variety …See details»
公司概况 - 深圳康泰生物制品股份有限公司 - Biokangtai
公司概况深圳康泰生物制品股份有限公司成立于1992年，专注于人用疫苗的研发、生产、销售，2017年2月在深交所创业板上市（股票代码 ：300601），为华南地区首个上市疫苗企业。 …See details»
Biokangtai - Crunchbase
Biokangtai is a listed company integrating research, development, production and sales of biological products.See details»
Biokangtai - Funding, Financials, Valuation & Investors - Crunchbase
Feb 7, 2017 Biokangtai has raised 2 rounds. Their latest funding was raised on Mar 1, 2018 from a Post-IPO Equity round. Biokangtai is registered under the ticker SZSE:300601 . Their stock …See details»
Shenzhen Kangtai Biological Products - ZoomInfo
Aug 31, 2022 Cooperation Agreement Concluded between BioKangtai and Biotis-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugate …See details»
研发概况 - 深圳康泰生物制品股份有限公司 - biokangtai.com
研发概况深圳康泰生物制品股份有限公司成立于1992年，专注于人用疫苗的研发、生产、销售，2017年2月在深交所创业板上市（股票代码 ：300601），为华南地区首个上市疫苗企业。 …See details»
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical …
Dec 1, 2020 BIOKANGTAI is China's leading biopharmaceutical enterprise. Over the past 30 years since its establishment, it has accumulated rich experience in vaccine research and …See details»
Biokangtai - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 Organization. Biokangtai . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 1,307. Monthly Visits …See details»
企业文化 - 深圳康泰生物制品股份有限公司 - Biokangtai
企业文化深圳康泰生物制品股份有限公司成立于1992年，专注于人用疫苗的研发、生产、销售，2017年2月在深交所创业板上市（股票代码 ：300601），为华南地区首个上市疫苗企业。 …See details»
Cooperative Project - Biokangtai
In the last 30 years, BioKangtai has produced over 1 billion doses of Hep B vaccines, contributed a lot to the public health in China. Cooperated with the Intravacc of Netherland in the …See details»
走进康泰 - 深圳康泰生物制品股份有限公司 - Biokangtai
走进康泰深圳康泰生物制品股份有限公司成立于1992年，专注于人用疫苗的研发、生产、销售，2017年2月在深交所创业板上市（股票代码 ：300601），为华南地区首个上市疫苗企业。 …See details»
News - Biokangtai
BioKangtai passed the EU QP audit quality management system and reached the EU GMP standard. 2022-02-24. Shenzhen starts offering Kangtai COVID booster shots. 2022-02-21. …See details»